Find recruiting clinical trials for ADHD in the UK � including inattentive type, hyperactive-impulsive type, and combined type in both adults and children. See treatment pathways and where trials fit in.
Free to use � Live data from ClinicalTrials.gov � Updated hourly
Answer a few questions about your condition and we'll match you to the most relevant clinical trials.
See where clinical trials fit into your treatment journey
Initial treatment for children
Standard: Methylphenidate (Ritalin, Concerta) + behavioural therapy
Initial treatment for adults
Standard: Lisdexamfetamine (Elvanse) or Methylphenidate + CBT
After inadequate response or intolerance
Standard: Atomoxetine (Strattera), Guanfacine, or clinical trial
Difficulty sustaining attention, easily distracted, forgetful. Often underdiagnosed because symptoms are less disruptive. More common in girls and women.
Fidgeting, excessive talking, difficulty waiting, interrupting others. More commonly recognised and diagnosed in childhood.
Both inattentive and hyperactive-impulsive symptoms. The most commonly diagnosed type of ADHD.
Loading trials from ClinicalTrials.gov...
Yes. Several trials investigate non-stimulant medications like Viloxazine (Qelbree), new formulations of Atomoxetine, and novel agents. These are especially relevant for patients who cannot tolerate stimulants.
Trials do not typically provide diagnostic services. You need an ADHD diagnosis before joining most trials. However, some observational studies may include diagnostic assessment as part of screening.
Yes. Non-drug trials investigate digital therapeutics (FDA-approved games like EndeavorRx), neurofeedback, cognitive training, CBT adaptations, and lifestyle interventions for ADHD.
Use our search above to find trials that match your condition and location. Review the eligibility criteria carefully.
Talk to your GP or specialist about any trials you are interested in. They can help determine if a trial is appropriate for you.
Reach out to the trial team directly using the contact information on the ClinicalTrials.gov listing. They will guide you through screening.
If you meet the criteria and decide to participate, you will go through informed consent and begin the trial process.